Fortress Biotech, Inc.
FBIO
|
$1.79
-1.11%
-1.4%
120K
|
Health Technology
(0.0% 1d) (-7.3% 1m) (145.2% 1y) (0.0% 2d) (-0.6% 3d) (2.3% 7d) (Infinity% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 34,429,802
http://www.fortressbiotech.com
Sec Filling | Patents | 93 employees
(US) Fortress Biotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The company was founded on June 28, 2006 and is headquartered in New York, NY.
add to watch list Paper trade email alert is off
Press-releases
Avenue Therapeutics Announces Reverse Stock Split
Published: 2024-04-24 (Crawled : 12:00) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
|
| O: -0.56%
H: 0.56%
C: 0.0%
ATXI | $0.0943 -29.63% -41.2% 74K
|
Health Technology
|
| O: -23.08%
H: 0.0%
C: -10.0%
therapeutics
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
| Email alert
Add to watchlist
CKPT | $1.44 0.35% 0.35% 1
|
Health Technology
| Email alert
Add to watchlist
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
| Email alert
Add to watchlist
MBIO | $0.3501 -2.67% -2.77% 120K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
| Email alert
Add to watchlist
DERM | $3.4 -3.96% -3.36% 60K
|
| Email alert
Add to watchlist
biotech financial results
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
MBIO | $0.3501 -2.67% -2.77% 120K
|
Health Technology
|
| O: 7.14%
H: 1.9%
C: -0.95%
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
|
| O: -0.46%
H: 0.46%
C: -7.41%
t-cell expansion vision therapy platform
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
|
| O: -0.78%
H: 2.6%
C: -0.52%
ATXI | $0.0943 -29.63% -41.2% 74K
|
Health Technology
|
| O: -1.46%
H: 7.38%
C: 4.03%
key therapeutics
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-22 (Crawled : 13:00) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
|
| O: -1.02%
H: 3.08%
C: -0.77%
CKPT | $1.44 0.35% 0.35% 1
|
Health Technology
|
| O: -0.53%
H: 5.29%
C: 2.65%
therapeutics financial results
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-21 (Crawled : 20:00) - globenewswire.com
DERM | $3.4 -3.96% -3.36% 60K
|
|
| O: -8.38%
H: 1.8%
C: -5.71%
SWKH | $17.01 -1.51% -0.99% 3.3K
|
Miscellaneous
|
| O: -1.23%
H: 4.63%
C: -0.68%
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
|
| O: -1.02%
H: 3.08%
C: -0.77%
corporation medical financial results
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-18 (Crawled : 20:00) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
|
| O: 2.08%
H: 0.51%
C: -3.32%
ATXI | $0.0943 -29.63% -41.2% 74K
|
Health Technology
|
| O: 3.75%
H: 2.41%
C: -3.61%
year therapeutics financial results
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
Published: 2024-03-18 (Crawled : 12:30) - globenewswire.com
DERM | $3.4 -3.96% -3.36% 60K
|
|
| O: 2.94%
H: 14.57%
C: 6.86%
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
|
| O: 3.36%
H: 0.5%
C: -4.0%
dfd-29 fda drug corporation treatment medical application
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
|
| O: 3.36%
H: 0.5%
C: -4.0%
CKPT | $1.44 0.35% 0.35% 1
|
Health Technology
|
| O: 0.52%
H: 4.07%
C: -2.07%
life sciences therapeutics
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
Published: 2024-03-15 (Crawled : 12:30) - globenewswire.com
DERM | $3.4 -3.96% -3.36% 60K
|
|
| O: -5.19%
H: 10.03%
C: 3.34%
FBIO | $1.79 -1.11% -1.4% 120K
|
Health Technology
|
| O: 2.98%
H: 15.03%
C: 11.85%
year corporation medical financial results
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Last 48 Hours Insiders Buying
MNSB P 1470 | $15.89 -2.87% -3.02% 46K
|
Finance
|
12:00
RKT P 347 | $12.55 -0.63% 1.12% 1.5M
|
Finance
|
22:30
NWFL | News | $24.21 0.42% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.68 -0.73% 39.71% 0
|
Utilities
|
20:01
RMCF | $3.55 0.28% 0.28% 7.1K
|
Consumer Non-Durables
|
20:10